GENNEX LABORATORIES
|
The Current P/S Ratio of GENNEX LABORATORIES is 2.72.
| Share Price | ₹16.5 | Oct 29,2025 |
| Market Cap | ₹401.5 Cr | |
| Sales-TTM | ₹147.9 Cr | TTM-Consolidated Results |
| Price/Sales | 2.72x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of GENNEX LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹401.5 Cr] as on Oct 29,2025
(/) Sales [ ₹147.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.72x ]
Thus, for GENNEX LABORATORIES , the investors are currently willing to pay '2.72 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GENNEX LABORATORIES !
The chart below summarizes the trend in P/S Ratio of GENNEX LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of GENNEX LABORATORIES
PS Ratio Performance Analysis for GENNEX LABORATORIES
- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.69x.
- GENNEX LABORATORIES 's operated at median p/e ratio of 1.51x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2024 at 4.14x.
- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.42x.
How does GENNEX LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| GENNEX LABORATORIES | 147.9 | 2.72 | 401.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.60 | 408,751.0 |
| DIVIS LABORATORIES LTD | 9,652.0 | 18.30 | 176,634.0 |
| CIPLA LTD | 27,811.2 | 4.47 | 124,437.0 |
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.30 | 121,871.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.92 | 100,333.0 |
| MANKIND PHARMA LTD | 12,956.2 | 7.79 | 100,950.0 |
| ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.20 | 99,244.9 |
| LUPIN LTD | 23,375.9 | 3.80 | 88,847.7 |
| AUROBINDO PHARMA LTD | 32,024.8 | 2.00 | 64,033.4 |
| ABBOTT INDIA LTD | 6,589.9 | 9.56 | 62,972.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GENNEX LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.00x |
| Max industry PS | 18.30x |
| Median industry PS | 4.47x |
| Average industry PS | 6.70x |
You may also like the below Video Courses